Results 41 to 50 of about 4,425,847 (185)
Chinese Journal of Cancer, 2010 Cytokine-induced killer (CIK) cells and autologous dendritic cells-CIK (DC-CIK) cells co-cultured with autologous dendritic cells (DCs) and CIK cells are commonly used for immunotherapy recently. We compared the anti-tumor immune response of CIK cells, autologous DC-CIK cells, and semi-allogeneic DC-CIK cells to explore a more effective anti-tumor ...
Qi-Jing, Wang +14 more
openaire +2 more sources
CD25highFoxP3+ T cells on CIK cells.
, 2023 Expression of CD25highFoxP3+ T cells were low on CIK cells and PBMCs (N = 3). (TIF)
Ching-Hsun Hu (14328999) +6 more
core +1 more source
Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer
Pathology and Oncology Research, 2023 Background: The therapeutic efficacy of cytokine-induced killer (CIK) cells versus dendritic cells (DC) co-cultured with CIK cells (DC-CIK) in treating esophageal cancer (EC) remains unclear due to the absence of a direct comparison of these two regimens.
Jiayang Sun +3 more
doaj +1 more source
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective [PDF]
Journal of Experimental & Clinical Cancer Research, 2021 AbstractEmerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.
Amit Sharma, Ingo G. H. Schmidt-Wolf
openaire +3 more sources
Expression profile of partial NK receptors on CIK cells.
, 2023 Expression of NKG2C, NKG2A, KIR, NKp46 and NKp44 were low on CIK cells and PBMCs (N = 5). (TIF)
Ching-Hsun Hu (14328999) +6 more
core +1 more source
Stem Cells International, 2023 Purpose. Dendritic cells (DC) are specialized antigen-presenting cells, and cytokine-induced killer (CIK) cells have a specific killing activity to a variety of tumors.
Min Dong +5 more
doaj +1 more source
Frontiers in Immunology, 2020 High-risk rhabdomyosarcoma (RMS) occurring in childhood to young adulthood is associated with a poor prognosis; especially children above the age of 10 with advanced stage alveolar RMS still succumb to the disease within a median of 2 years.
Michael Merker +24 more
doaj +1 more source
How can Cytokine-induced killer cells overcome CAR-T cell limits
Frontiers in Immunology, 2023 The successful treatment of patients affected by B-cell malignancies with Chimeric Antigen Receptor (CAR)-T cells represented a breakthrough in the field of adoptive cell therapy (ACT).
Elisa Cappuzzello +7 more
doaj +1 more source
Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy [PDF]
Clinical and Developmental Immunology, 2013 Objective. To evaluate the efficacy of autologous cytokine-induced killer (CIK) cells in patients with renal cell carcinoma (RCC).Methods. 20 patients diagnosed with TNM stage I or II RCC were randomly divided into two groups, a CIK cell treatment group and a control group.
Yajing Zhang +11 more
openaire +3 more sources
Effect of DC-CIK cell on the proliferation, apoptosis and differentiation of leukemia cells
Asian Pacific Journal of Tropical Medicine, 2014 To observe the effect of co-culture cytokine-induced killer cells (CIK) and homologous dendritic cells (DC) on the proliferative activity and phenotype change of the DC-CIK cell and the cell killing activity of leukemia HL-60.50 mL cord blood sample was obtained from infants delivered by full term healthy woman and the cord blood mononuclear cells were
Qu, Hui-Qing +3 more
openaire +2 more sources